<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858700</url>
  </required_header>
  <id_info>
    <org_study_id>8271</org_study_id>
    <nct_id>NCT02858700</nct_id>
  </id_info>
  <brief_title>Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection</brief_title>
  <acronym>PCT_CORDON</acronym>
  <official_title>Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After birth, in the presence of risk factors for early neonatal bacterial infection (IBNP),&#xD;
      the pediatrician must make a difficult decision quickly or not to prescribe additional&#xD;
      examinations and / or hospitalize or not the newborn in order to administer parenteral&#xD;
      antibiotics. This decision takes into account several contextual data, (clinical, biological&#xD;
      and bacteriological clinical data) to be considered simultaneously. These information lack&#xD;
      sensitivity and specificity.&#xD;
&#xD;
      Therefore, the common attitude among newborns in many countries remains the achievement of a&#xD;
      significant number of additional tests and the establishment, without a prior evidence of&#xD;
      infection, intravenous empirical antibiotic therapy for 48 -72h at least in hospitalization.&#xD;
      However, the diagnosis of IBNP posteriori, is often reversed. This attitude is:&#xD;
&#xD;
        1. one source to higher health care costs (hospitalization, additional examinations)&#xD;
&#xD;
        2. Selection of the bacterial ecology of the newborn and neonatal services and&#xD;
&#xD;
        3. stress for the newborn and parents&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>value of the procalcitonin in the umbilical cord blood</measure>
    <time_frame>up to 1 hour</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">550</enrollment>
  <condition>Neonatal Bacterial Infection</condition>
  <arm_group>
    <arm_group_label>umbilical cord blood procalcitonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP</intervention_name>
    <arm_group_label>umbilical cord blood procalcitonin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Birth to motherhood.&#xD;
&#xD;
          -  Term &gt; 34 weeks .&#xD;
&#xD;
          -  Presence of at least one of the factors of major or minor infection risk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cord blood sample unavailable.&#xD;
&#xD;
          -  Death in the delivery room&#xD;
&#xD;
          -  Corticosteroids prenatally (modification of cytokine production ) .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Minutes</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University hospital of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>August 5, 2016</last_update_submitted>
  <last_update_submitted_qc>August 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neonatal bacterial infection</keyword>
  <keyword>procalcitonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

